The Lancet4h
Transforming amyotrophic lateral sclerosis into a liveable disease
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...
FierceBiotech1d
FDA gives Amylyx green light for phase 1 ALS trial after clinical hold
After raising questions surrounding dosing levels, the FDA has freed Amylyx’s early-stage amyotrophic lateral sclerosis (ALS) ...
The Standard-Times on MSN1d
New Bedford man stole over $450K from disabled veteran. Here's what we know.
Hundreds of thousands in monthly veteran benefits were stolen by New Bedford man. Here's what he was sentenced: ...
BioSpace16h
FDA Presses Pause on Atara’s Programs, Play on Amylyx’s ALS Assets
The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a ...
Hosted on MSN1d
FDA lifts clinical hold on Amylyx’s Phase I ALS trial
This is the latest venture for Amylyx into the ALS field after its previous therapy Relyvrio was pulled from the market in ...
labiotech15h
Curing ALS? Thirteen companies developing new treatments in 2025
Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.
GlobalData on MSN2d
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment
The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...
BioSpace12d
HEALEY ALS Trial Serves Up More Disappointment as Denali, AbbVie/Calico Fail
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...
Mass. man who stole over $450K in benefits from veteran with ALS to go to prison
A New Bedford man was sentenced to prison for conspiring to steal and then depositing over $450,000 from a U.S. Marine ...
Daily3d
Zydus Lifesciences gets USFDA nod to conduct Phase II(b) clinical trial for Usnoflast for Amyotrophic Lateral Sclerosis
Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that it has received approval from USFDA to ...
WWLP Springfield on MSN4d
New Bedford man sentenced to prison for stealing veteran’s disability benefits
A New Bedford man was sentenced to prison in federal court on Friday for stealing over $450,000 in disability benefits that ...
Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains
Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...